Feasibility of Omitting Sentinel Lymph Node Biopsy in an Under-screened Cohort of Breast Cancer Patients With a Premastectomy Diagnosis of Ductal Carcinoma In Situ

CONCLUSION: In a cohort who had DCIS diagnosis before mastectomy and were mostly symptomatic, the upgrade rate was 51.3%. Despite the high upgrade rate, nodal involvement remained comparable. Risk factors could select patients for omission of upfront SLNB, with a delayed SLNB planned if needed.PMID:38458843 | DOI:10.1016/j.clbc.2024.02.002

Source: Clinical Genitourinary Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Jinnie Pang Zhiyan Yan Qing Ting Tan John C Allen Mingjia Wang Geok Hoon Lim Source Type: research